ADAM28 is activated by MMP-7 (matrilysin-1) and cleaves insulin-like growth factor binding protein-3
- PMID: 15013428
- DOI: 10.1016/j.bbrc.2004.01.022
ADAM28 is activated by MMP-7 (matrilysin-1) and cleaves insulin-like growth factor binding protein-3
Abstract
ADAM28, a member of a disintegrin and metalloproteinase (ADAM) family, has two isoforms, membrane-type form (ADAM28m) and secreted form (ADAM28s). Although ADAM28 is expressed and synthesized in a precursor form (proADAM28) by lymphocytes and some cancer cells, its activation mechanism and substrates remain unclear. Here, we report that proADAM28s of 65kDa is processed with active matrix metalloproteinase-7 (MMP-7) to 42- and 40-kDa forms which corresponds to active ADAM28s without propeptide. Processed ADAM28s digested insulin-like growth factor binding protein-3 (IGFBP-3) in both free and complex forms with IGF-I or IGF-II, and the digestion was prevented with EDTA, 1,10-phenanthroline, KB-R7785, tissue inhibitor of metalloproteinases-3 (TIMP-3), and TIMP-4. These data provide the first evidence that proADAM28s is activated by MMP-7 and ADAM28 digests IGFBP-3.
Similar articles
-
ADAM28 is overexpressed in human breast carcinomas: implications for carcinoma cell proliferation through cleavage of insulin-like growth factor binding protein-3.Cancer Res. 2006 Oct 15;66(20):9913-20. doi: 10.1158/0008-5472.CAN-06-0377. Cancer Res. 2006. PMID: 17047053
-
Modulation of the microenvironment and adhesion of cancer cells by ADAMs (a disintegrin and metalloproteinase).Verh Dtsch Ges Pathol. 2007;91:29-38. Verh Dtsch Ges Pathol. 2007. PMID: 18314593
-
Expression and enzymatic activity of human disintegrin and metalloproteinase ADAM19/meltrin beta.Biochem Biophys Res Commun. 2001 Jan 26;280(3):744-55. doi: 10.1006/bbrc.2000.4200. Biochem Biophys Res Commun. 2001. PMID: 11162584
-
ADAM28 as a target for human cancers.Curr Pharm Des. 2009;15(20):2349-58. doi: 10.2174/138161209788682424. Curr Pharm Des. 2009. PMID: 19601836 Review.
-
Regulation of matrilysin in the rat uterus.Biochem Cell Biol. 1996;74(6):777-84. doi: 10.1139/o96-084. Biochem Cell Biol. 1996. PMID: 9164647 Review.
Cited by
-
Pericellular proteolysis in cancer.Genes Dev. 2014 Nov 1;28(21):2331-47. doi: 10.1101/gad.250647.114. Genes Dev. 2014. PMID: 25367033 Free PMC article. Review.
-
TIMP-3 as a therapeutic target for cancer.Ther Adv Med Oncol. 2019 Jul 16;11:1758835919864247. doi: 10.1177/1758835919864247. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31360238 Free PMC article. Review.
-
Unraveling insulin-like growth factor binding protein-3 actions in human disease.Endocr Rev. 2009 Aug;30(5):417-37. doi: 10.1210/er.2008-0028. Epub 2009 May 28. Endocr Rev. 2009. PMID: 19477944 Free PMC article. Review.
-
SheddomeDB: the ectodomain shedding database for membrane-bound shed markers.BMC Bioinformatics. 2017 Mar 14;18(Suppl 3):42. doi: 10.1186/s12859-017-1465-7. BMC Bioinformatics. 2017. PMID: 28361715 Free PMC article. Review.
-
Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implications.Biochem J. 2010 Oct 1;431(1):113-22. doi: 10.1042/BJ20100725. Biochem J. 2010. PMID: 20645923 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous